Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors

Clinical trial NCT04400383 · COMPLETED

Trial details

NCT number: NCT04400383
Sponsor: CARsgen Therapeutics Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Gastric Cancer Pancreatic Adenocarcinoma

Start date: 2020-06-04
Primary completion: 2023-07-08
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.